Low bone mass in Noonan syndrome children correlates with decreased muscle mass and low IGF-1 levels
Low bone mass in Noonan syndrome children correlates with decreased [...]
Low bone mass in Noonan syndrome children correlates with decreased [...]
Identification of the third FGF9 variant in a girl with [...]
Presenting features and molecular genetics of primary hyperparathyroidism in the [...]
Lethal Encephalopathy in an Infant with Hypophosphatasia despite Enzyme Replacement [...]
Utility of genetic testing for prenatal presentations of hypophosphatasia Sperelakis-Beedham [...]
Hypophosphatasia: A Case of Two Patients With Spinal Cord Compression [...]
The Treatment of Recurrent Congential clubfoot Radler C. Foot Ankle [...]
Caffey disease is associated with distinct arginine to cysteine substitutions [...]
Safe and persistent growth-promoting effects of vosoritide in children with [...]
Lifetime impact of achondroplasia: Current evidence and perspectives on the [...]

ERN-BOND is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are Funded by the European Commission. For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern
Funded by the European Union
ERN BOND Specific Grant Agreement no. 101157116

Coordinating Center
Istituto Ortopedico Rizzoli
via G.C.Pupilli, 1 – 40136 Bologna – Italy
“Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them.”

Co-funded by the European Union
ERN BOND Specific Grant Agreement no. 101157116

Coordinating Center
Istituto Ortopedico Rizzoli
via G.C.Pupilli, 1 – 40136 Bologna – Italy
The contents of this website represents the views of the network and is its sole responsibility; and do not necessarily reflect the opinion of the European Union
Privacy and cookie policy